A Study to Compare Microembolic Signal Detection and Cerebral Vasomotor Reactivity on Transcranial Doppler in Patients with Left Ventricular Assistance Devices

Overview

About this study

The purpose of this study is to compare microembolic signal detection (MSD) and cerebral vasomotor reactivity (CVR) on transcranial doppler in patients with left ventricular assistance devices.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

18 years or older.
with a diagnosis of chronic congestive heart failure status post ventricular assistance device placement.

Exclusion Criteria:

Malignancy, end stage liver disease, sickle cell disease, end stage renal disease, internal cerebral artery stenosis, occlusion or hemorrhagic plaque, MCA stenosis, vasculitis, artificial heart valves, endocarditis, contrast echocardiography within 1 week.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Michelle Lin, M.D., M.P.H.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Michelle Lin, M.D., M.P.H.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials